Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Qinjing, Pan"'
Autor:
Hongmei Yang, Yubing Hao, Meili Niu, Jie Zheng, Xinhua Jia, Shaokai Zhang, Libing Wang, Xun Zhang, Qinjing Pan, Xiangxian Feng, Youlin Qiao, Zhifang Li
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
ObjectiveThe research focused on a comparative analysis of triage strategies for women with Atypical Squamous Cells of Undetermined Significance (ASC-US) before and after receiving the HPV vaccine, aiming to optimize cervical cancer prevention strate
Externí odkaz:
https://doaj.org/article/03a4cced830240959b4754ffafa525d7
Performance of Human Gene EPB41L3 and HPV 16/18 Viral DNA Methylation to Triage hrHPV-Positive Women
Autor:
Remila Rezhake, Yan Wang, Xuelian Zhao, Marc Arbyn, Guqun Shen, Qinjing Pan, Xun Zhang, Yuanming Zhang, Fanghui Zhao, Youlin Qiao
Publikováno v:
Vaccines, Vol 12, Iss 1, p 46 (2023)
More evidence from population-based cohort studies is required to confirm the application of methylation-based biomarkers in real-world settings. The cross-sectional and 24-month cumulative triage performance of a novel methylation assay targeting th
Externí odkaz:
https://doaj.org/article/533f93693d694f079fee4433f5697a53
Autor:
Zeni Wu, Tingyuan Li, Yongli Han, Mingyue Jiang, Yanqin Yu, Huifang Xu, Lulu Yu, Jianfeng Cui, Bin Liu, Feng Chen, Jian Yin, Xun Zhang, Qinjing Pan, Youlin Qiao, Wen Chen
Publikováno v:
BMC Medicine, Vol 19, Iss 1, Pp 1-9 (2021)
Abstract Background Current methods for cervical cancer screening result in an increased number of referrals and unnecessary diagnostic procedures. This study aimed to develop and evaluate a more accurate model for cervical cancer screening. Methods
Externí odkaz:
https://doaj.org/article/b66ce447d9ff4cd1880a2ef18b86d545
Autor:
Shangying Hu, Xiaoqian Xu, Fengcai Zhu, Ying Hong, Yuemei Hu, Xun Zhang, Qinjing Pan, Wenhua Zhang, Chengfu Zhang, Xiaoping Yang, Jiaxi Yu, Jiahong Zhu, Yejiang Zhu, Feng Chen, Shuang Zhao, Naveen Karkada, Haiwen Tang, Dan Bi, Frank Struyf, Fanghui Zhao
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 4, Pp 955-964 (2021)
Human papillomavirus (HPV) vaccines are efficacious against HPV infections and associated lesions in women HPV-naïve at vaccination. However, vaccine efficacy (VE) against oncogenic, high-risk HPV (HR-HPV) types in women infected with any other HR-H
Externí odkaz:
https://doaj.org/article/a714e90d323d46e2bac37315b739bea5
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background It is widely acknowledged that HPV prophylactic vaccine could prevent new infections and their associated lesions among women who are predominantly HPV-naive at vaccination. Yet there still remains uncertainty about whether HPV va
Externí odkaz:
https://doaj.org/article/371797ca813d4268a210855361ab3868
Autor:
Xingmei Yao, Wen Chen, Chao Zhao, Lihui Wei, Yuemei Hu, Mingqiang Li, Zhijie Lin, Bizhen Lin, Xiaohui Liu, Ying Hong, Qing Li, Qinjing Pan, Xun Zhang, Mingzhu Li, Yuqian Zhao, Li Zhang, Huifang Xu, Fangfang Hu, Jun Zhao, Yue Huang, Wei Sheng, Ya Zheng, Shangying Hu, Yingying Su, Shoujie Huang, Huirong Pan, Fanghui Zhao, Youlin Qiao, Ting Wu, Jun Zhang, Ningshao Xia
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 13, Iss , Pp 100196- (2021)
Summary: Background: Although recent studies have suggested that naturally acquired Human papillomavirus (HPV) antibodies are partly protective against subsequent homotypic infection, the extent of protection remains indecisive. Here, we evaluate the
Externí odkaz:
https://doaj.org/article/af023f77267847b2978357d5f38d3357
Publikováno v:
IEEE Journal of Solid-State Circuits. 58:1735-1745
Publikováno v:
IEEE Journal of Solid-State Circuits. 58:796-805
Autor:
Remila Rezhake, Yan Wang, Guqun Shen, Xuelian Zhao, Qinjing Pan, Xun Zhang, Marc Arbyn, Yuanming Zhang, Fanghui Zhao, Youlin Qiao
Background: Methylation-based biomarkers show promise in triaging hrHPV positive women, however, more evidence from population-based prospective studies is required to confirm its utility in real-world settings. Methods: 2000 women from Xinjiang, Chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bacae8267296923261a00cfbd8332fea
https://doi.org/10.21203/rs.3.rs-2071023/v1
https://doi.org/10.21203/rs.3.rs-2071023/v1
Autor:
Fanghui Zhao, Archana Jastorff, Ying Hong, Shangying Hu, Wen Chen, Xiaoqian Xu, Yejiang Zhu, Jiahong Zhu, Xun Zhang, Wenhua Zhang, Dacheng Xu, Dali Wang, Rong Tang, Yonghong Sun, Yiping Shen, Qinjing Pan, Jian Yin, Daokuan Liu, Bin Liu, Naveen Karkada, Chunmei Jiang, Jianfeng Cui, Feng Chen, Jun Bi, Yuqing Bao, Xin Zhou, Cyrille Cartier, Yuemei Hu, Dorota Borys
Publikováno v:
Asia-Pacific Journal of Clinical Oncology.
The pivotal efficacy study assessed efficacy and safety of GSK's AS04-HPV-16/18 vaccine in Chinese women aged 18-25 years up to 6 years. The present extension study, performed 4 years later, offered AS04-HPV-16/18 vaccination to placebo recipients. V